Related references
Note: Only part of the references are listed.ER stress induced by ionising radiation in IEC-6 cells
Bo Zhang et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2010)
The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE2 signalling in colorectal adenoma cells
A. Greenhough et al.
ONCOGENE (2010)
15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells
Xiuling Chi et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
HGF/Met signalling promotes PGE2 biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells
Amy E. Moore et al.
CARCINOGENESIS (2009)
The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
Alexander Greenhough et al.
CARCINOGENESIS (2009)
15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Gastric Cancer
Alexandra Thiel et al.
CLINICAL CANCER RESEARCH (2009)
15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors
Min Yan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Jihye Yun et al.
SCIENCE (2009)
Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib
Adel Kardosh et al.
CANCER RESEARCH (2008)
15-hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3β and a tumor suppressor in lung cancer
Guosheng Huang et al.
CANCER RESEARCH (2008)
HYPOXIA AND METABOLISM SERIES - TIMELINE The impact of O2 availability on human cancer
Jessica A. Bertout et al.
NATURE REVIEWS CANCER (2008)
Hypoxia and metabolism - Opinion - A microenvironmental model of carcinogenesis
Robert A. Gatenby et al.
NATURE REVIEWS CANCER (2008)
Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer
Li Yang et al.
CANCER RESEARCH (2007)
Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase
Saswati Hazra et al.
MOLECULAR PHARMACOLOGY (2007)
Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia
Abderrahmane Kaidi et al.
NATURE CELL BIOLOGY (2007)
The tumour microenvironment as a target for chemoprevention
Adriana Albini et al.
NATURE REVIEWS CANCER (2007)
Celecoxib for the prevention of sporadic colorectal adenomas
Monica M. Bertagnolli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis
Seung-Jae Myung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer
Ido Wolf et al.
CANCER RESEARCH (2006)
Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression
Jason R. Mann et al.
CANCER RESEARCH (2006)
Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia
Abderrahmane Kaidi et al.
CANCER RESEARCH (2006)
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Esther A. Obeng et al.
BLOOD (2006)
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
DZ Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence
SD Chell et al.
CANCER RESEARCH (2006)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Endoplasmic reticulum stress: cell life and death decisions
CY Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
15-hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer
MG Backlund et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer
YF Ding et al.
CARCINOGENESIS (2005)
Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosis
S Tsutsumi et al.
CELL DEATH AND DIFFERENTIATION (2004)
15-hydroxyprostagland in dehydrogenase, a COX-2 oncogene antagonist, is a TGF-β-induced suppressor of human gastrointestinal cancers
M Yan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The role of the unfolded protein response in tumour development: Friend or foe?
YJ Ma et al.
NATURE REVIEWS CANCER (2004)
Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappa B/I kappa B pathway
Marie-Eve St-Germain et al.
MOLECULAR CANCER (2004)
Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression
DJE Elder et al.
JOURNAL OF PATHOLOGY (2002)
Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis
M Stolina et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
